APC Anti-Human CD44 Antibody[Hermes-1]

Introducing the APC Anti-Human CD44 Antibody [HERMES-1], a highly advanced and meticulously crafted product designed to cater to the needs of the scientific community. This antibody, available in a convenient size of 100 tests, is an indispensable tool for researchers seeking to delve deeper into the intricacies of human CD44.

Crafted with utmost precision and expertise, the APC Anti-Human CD44 Antibody [HERMES-1] offers unparalleled accuracy and reliability in its performance. Its cutting-edge technology ensures optimal results, enabling researchers to obtain precise and reproducible data.

This antibody is specifically engineered to target human CD44, a crucial cell surface glycoprotein involved in various physiological and pathological processes. By selectively binding to CD44, this antibody facilitates the identification and analysis of CD44-expressing cells, enabling researchers to gain valuable insights into cellular functions and disease mechanisms.

The APC Anti-Human CD44 Antibody [HERMES-1] boasts exceptional sensitivity and specificity, ensuring minimal background noise and maximum signal intensity. Its advanced formulation guarantees minimal cross-reactivity, allowing for precise discrimination between CD44-positive and CD44-negative cells.

Furthermore, this antibody is conjugated with APC (Allophycocyanin), a highly stable and bright fluorochrome, which enhances the detection sensitivity and enables multi-color flow cytometry experiments. The APC Anti-Human CD44 Antibody [HERMES-1] is compatible with a wide range of flow cytometry platforms, making it a versatile choice for researchers across various disciplines.

In summary, the APC Anti-Human CD44 Antibody [HERMES-1] is a state-of-the-art product that combines cutting-edge technology, exceptional performance, and ease of use. With its superior accuracy, sensitivity, and specificity, this antibody is an invaluable asset for researchers aiming to unravel the complexities of human CD44.